Analysis of sequential aliquots of hypertonic saline solution-induced sputum from clinically stable patients with cystic fibrosis

Chest

Volumn 123, Issue 3, 2003, Pages 792-799

  Aitken, Moira L ^a,d   Greene, Kelly E ^c   Tonelli, Mark R ^a   Burns, Jane L ^b   Emerson, Julia C ^b   Goss, Christopher H ^a   Gibson, Ronald L ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d Division of Pulmonary and Critical Care Medicine   (United States)

Author keywords

Cystic fibrosis; Hypertonic saline; Sputum

Indexed keywords

INTERLEUKIN 8; SODIUM CHLORIDE; SURFACTANT PROTEIN A; UREA;

ADULT; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; FORCED EXPIRATORY VOLUME; HUMAN; HYPOTHESIS; INFORMATION PROCESSING; LUNG ALVEOLUS MACROPHAGE; MALE; MICROBIOLOGICAL EXAMINATION; NEUTROPHILIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SAMPLE; SPUTUM EXAMINATION; SQUAMOUS CELL; STAPHYLOCOCCUS AUREUS;

EID: 0037338508     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.3.792     Document Type: Article

References (40)

1. Robinson M, Regnis J, Bailey D, et al. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Am J Respir Crit Care Med 1996; 153:1503-1509
2. Eng P, Morton J, Douglass J, et al. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatr Pulmonol 1996; 21:77-83
3. DeBoeck K, Alifier M, Vandeputte A. Sputum induction in young cystic fibrosis patients. Eur Respir J 2000; 16:91-94
4. Rodwell L, Anderson S. Airway responsiveness to hyperosmolar saline challenge in cystic fibrosis: a pilot study. Pediatr Pulmonol 1996; 21:282-289
5. Pin I, Gibson P, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992; 47:25-29
6. Fahy J, Fleming H, Wong H, et al. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Bespir Crit Care Med 1997; 15.5:1828-1834
7. Pizzichini M, Popov T, Efthimiadis A, et al. Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med 1996; 154:866-869
8. Kips J, Fahy J, Hargreave F, et al. Methods for sputum induction and analysis of induced sputum method for assessing airway inflammation in asthma. Eur Respir J 1998; 11:9S-12S
9. Fahy J, Liu J, Wong H, et al. Cellular and biochemical analysis of induced sputum from healthy and asthmatic subjects. Am Rev Respir Dis 1993; 147:1126-1131
10. Pin I, Freitag AP, O'Byrne PM, et al. Changes in the cellular profile of iuduced sputum after allergen-induced asthmatic responses. Am Rev Respir Dis 1992; 145:1265-1269
11. Keatings V, Collins PD, Scott DM, et al. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153:530-534
12. Bhowmik A, Seemungal TA, Sapsford R, et al. Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax 1998; 53:953-956
13. Gibson P, Gabardo A, Morris M, et al. Cellular characteristics of sputum from patients with asthma and chronic bronchitis. Thorax 1989; 44:693-699
14. Henig N, Tonelli M, Pier M, et al. Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis. Thorax 2001; 56:306-311
15. Ordonez C, Stulbarg M, Grunland H, et al. The safety and reproducibility of sputum induction to measure airway inflammation in adults with cystic fibrosis [abstract]. Pediatr Pulmonol 2000; 20(suppl):A319
16. Ordonez C, Remold-O'donnell E, Wohl M. The feasibility, safety and repeatability of sputum induction to study infection and airway inflammation in children with cystic fibrosis [abstract]. Pediatr Pulmonol 2000; 20(Suppl):A320
17. Rosenfeld M, Emerson J, Accurso F, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999; 28:321-328
18. Baughman R, Keeton D, Perez C, et al. Use of bronchoalveolar lavage semiquantitative cultures in cystic fibrosis. Am J Respir Crit Care Med 1997; 156:286-291
19. Ramsey B, Wentz K, Smith A, et al. Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. Am Rev Respir Dis 1991; 144:331-337
20. Burns J, Gibson R, McNamara S, et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 2001; 183:444-452
21. Armstrong D, Grimwood K, Carlin J, et al. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol 1996; 21:267-275
22. Nixon G, Armstrong D, Carzino R, et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001; 138:699-704
23. 1-antitrypsin treatment for cystic fibrosis. Lancet 1991; 337:392-394
24. McElvaney N, Nakamura H, Birrer P, et al. Modulation of airway inflammation in cystic fibrosis: in vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J Clin Invest 1992; 90:1296-1301
25. Aitken M, Moss R, Waltz D, et al. A phase 1 study of aerosolized administration of tgAAVCF to CF patients with mild lung disease. Hum Gene Ther 2001; 12:1907-1916
26. Khan T, Wagener J, Bost T, et al. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995; 151:939-941
27. Balough K, MeCubbin M, Weinberger M, et al. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol 1995; 20:63-70
28. Meyer K, Sharma A. Regional variability of lung inflammation in cystic fibrosis. Am J Respir Crit Care Med 1997; 156:1536-1540
29. 4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis. Am Rev Respir Dis 1993; 148:896-901
30. Konstan M, Hilliard K, Norvell T, et al. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mold lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994; 1994:448-454
31. Ratjen F, Rietschel E, Griese M, et al. Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function; Bronchoalveolar Lavage for the Evaluation of Anti-inflammatory Treatment (BEAT) study group. Eur Respir J 2000; 151:141-145
32. Picard E, Schwartz S, Goldberg S, et al. A prospective study of fever and bacteremia after flexible fiberoptic bronchoscopy in children. Chest 2000; 117:573-577
33. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136
34. Fahy J, Liu J, Wong H, et al. Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation. J Allergy Clin Immunol 1994; 93:1031-1039
35. Greene K, Wright J, Steinberg K, et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 1999; 160:1843-1850
36. Burns J, Emerson J, Stapp J, et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 1998; 27:158-163
37. Wagener J, Rock M, McCubbin M, et al. Aerosol delivery and safety of recombinant human deoxyribonuclease in young children with cystic fibrosis: a bronchoscopic study. J Pediatr 1998; 133:486-491
38. Gershman N, Liu H, Wong H, et al. Fractional analysis of sequential induced sputum samples during sputum induction: evidence that different lung compartments are sampled at different time points. J Allergy Clin Immunol 1999; 104:322-328
39. Folkesson H, Kheradmand F, Mathay M. The effect of saltwater on alveolar epithelial barrier function. Am J Respir Crit Care Med 1994; 150:1555-1563
40. von Bredow C, Birrer P, Griese M. Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis. Eur Respir J 2001; 17:716-722